StockStory.org on MSN
Gilead Sciences (GILD): Buy, sell, or hold post Q1 earnings?
Since December 2025, Gilead Sciences has been in a holding pattern, posting a small return of 2.7% while floating around $124 ...
Scientific American used expert recommendations and data analysis to identify 28 exceptional early-career researchers Americans trust federal scientists more than RFK, Jr., poll suggests Russia’s war ...
Zacks Investment Research on MSN
Wave Life Sciences (WVE) upgraded to buy: Here's why
Wave Life Sciences (WVE) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- ...
Uncertainty is a defining feature of the modern world—from climate change and pandemics to financial instability, cybersecurity threats, and disruptive technologies. In a new article published in Risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results